• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌切除术后的无病生存期和复发情况。

Disease-free survival and recurrence after resection of colorectal carcinoma.

作者信息

Pihl E, Hughes E S, McDermott F T, Milne B J, Price A B

出版信息

J Surg Oncol. 1981;16(4):333-41. doi: 10.1002/jso.2930160406.

DOI:10.1002/jso.2930160406
PMID:7253653
Abstract

Recurrence data from a series of 1,315 colorectal cancer patients managed by one surgeon with potentially curative resection are presented. Complete follow-up information was available on 1,287 (98%) patients. At the time of the last recurrences, 164 and 232 months for rectal and colonic tumours respectively, the long-time recurrence rate was significantly (P = 0.001) higher for rectal tumours (42%) than for colonic (33%). Although local recurrences tended to be more common in rectal than in colonic tumours (18% compared to 15%), only those in contiguity with the operative area were significantly (P less than 0.005) more common in rectal tumours. Systemic recurrences were also significantly (P less than 0.025) commoner for rectal tumours. The greater recurrence rates in rectal tumours were associated with significantly (P less than 0.001) higher incidence of stage C tumours shorter recurrence-free survival in rectal stage C tumours (P = 0.001) and higher incidence of pulmonary metastases (P less than 0.001).

摘要

本文呈现了由一位外科医生进行潜在根治性切除治疗的1315例结直肠癌患者的复发数据。1287例(98%)患者有完整的随访信息。在最后一次复发时,直肠癌和结肠癌分别为164个月和232个月,直肠癌的长期复发率(42%)显著高于结肠癌(33%)(P = 0.001)。虽然局部复发在直肠癌中比在结肠癌中更常见(分别为18%和15%),但只有与手术区域相邻的局部复发在直肠癌中显著更常见(P < 0.005)。全身复发在直肠癌中也显著更常见(P < 0.025)。直肠癌较高的复发率与C期肿瘤的发生率显著更高(P < 0.001)、直肠癌C期肿瘤的无复发生存期更短(P = 0.001)以及肺转移的发生率更高(P < 0.001)相关。

相似文献

1
Disease-free survival and recurrence after resection of colorectal carcinoma.结直肠癌切除术后的无病生存期和复发情况。
J Surg Oncol. 1981;16(4):333-41. doi: 10.1002/jso.2930160406.
2
Local recurrence after curative resection in patients with colon and rectal cancers.结肠癌和直肠癌患者根治性切除术后的局部复发
Int J Colorectal Dis. 2008 Nov;23(11):1081-7. doi: 10.1007/s00384-008-0530-0. Epub 2008 Aug 8.
3
Lung recurrence after curative surgery for colorectal cancer.
Dis Colon Rectum. 1987 Jun;30(6):417-9. doi: 10.1007/BF02556487.
4
Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma.结直肠癌非肝转移复发的外科治疗结果
Cancer. 1993 Jun 15;71(12 Suppl):4267-77. doi: 10.1002/1097-0142(19930615)71:12+<4267::aid-cncr2820711816>3.0.co;2-o.
5
Comparative results of surgical management of single carcinomas of the colon and rectum: a series of 1939 patients managed by one surgeon.结肠和直肠癌单发病灶手术治疗的对比结果:由一位外科医生治疗的1939例患者系列研究
Br J Surg. 1981 Dec;68(12):850-5. doi: 10.1002/bjs.1800681207.
6
[Anastomotic recurrence following colorectal cancer].[结直肠癌术后吻合口复发]
Zentralbl Chir. 1988;113(22):1445-52.
7
Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.结直肠癌新临床病理分期系统的验证
Ann Surg. 1991 Jul;214(1):11-8. doi: 10.1097/00000658-199107000-00003.
8
Long-term results of laparoscopic versus open colorectal resections for cancer in 235 patients with a minimum follow-up of 5 years.235例癌症患者接受腹腔镜与开腹结直肠癌切除术的长期结果,最短随访5年。
Surg Endosc. 2006 Apr;20(4):546-53. doi: 10.1007/s00464-005-0338-8. Epub 2006 Feb 27.
9
Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.对随访至少十年的结直肠癌患者进行根治性切除术后的复发模式。
Hepatogastroenterology. 2003 Sep-Oct;50(53):1362-6.
10
Pattern, Stage, and Time of Recurrent Colorectal Cancer After Curative Surgery.根治性手术后复发性结直肠癌的模式、阶段和时间。
Clin Colorectal Cancer. 2019 Jun;18(2):e223-e228. doi: 10.1016/j.clcc.2019.01.003. Epub 2019 Jan 29.

引用本文的文献

1
HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic.组蛋白去乙酰化酶/σ1受体双配体作为靶向性黑色素瘤治疗药物
Pharmaceuticals (Basel). 2025 Jan 28;18(2):179. doi: 10.3390/ph18020179.
2
Anastomotic Recurrence After Curative Resection for Colorectal Cancer.结直肠癌根治性切除术后的吻合口复发
World J Surg. 2017 Jan;41(1):285-294. doi: 10.1007/s00268-016-3663-2.
3
Can colorectal cancer be prevented or treated by oral hormone replacement therapy?口服激素替代疗法能否预防或治疗结直肠癌?
Curr Mol Pharmacol. 2009 Nov;2(3):285-92. doi: 10.2174/1874467210902030285.
4
Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells.丹参酮 II-A 对人结肠癌细胞侵袭转移的抑制作用。
Acta Pharmacol Sin. 2009 Nov;30(11):1537-42. doi: 10.1038/aps.2009.139. Epub 2009 Oct 12.
5
GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?结直肠癌中的GCC信号传导:结直肠癌是一种旁分泌缺陷综合征吗?
Drug News Perspect. 2009 Jul-Aug;22(6):313-8. doi: 10.1358/dnp.2009.22.6.1395254.
6
Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway.MSP58的下调通过调节细胞周期蛋白D1-细胞周期蛋白依赖性激酶4-p21途径抑制人结肠癌细胞的生长。
Cancer Sci. 2009 Sep;100(9):1585-90. doi: 10.1111/j.1349-7006.2009.01223.x. Epub 2009 May 19.
7
Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance.挪威结直肠癌根治术后的系统随访:一项基于人群的有效性、成本和依从性审计
J Gastrointest Surg. 2005 Mar;9(3):320-8. doi: 10.1016/j.gassur.2004.09.023.
8
Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.鸟苷酸环化酶C是人类肠外组织中转移性结直肠癌肿瘤的一个选择性标志物。
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14827-32. doi: 10.1073/pnas.93.25.14827.
9
Sepsis and asepsis in large bowel cancer surgery.大肠癌手术中的脓毒症与无菌操作
World J Surg. 1982 Mar;6(2):160-5. doi: 10.1007/BF01654683.
10
A time saving but effective approach to the follow-up of patients after curative surgery of the large bowel.一种用于大肠根治性手术后患者随访的省时且有效的方法。
Ann R Coll Surg Engl. 1984 Mar;66(2):145.